Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it will receive CNY 100,000,000 equity round of funding on November 15, 2023. The transaction include the participation from returning investor Zhejiang Jiuzhou Pharmaceutical Co. The transaction has been approved at the 39th meeting of the company's 7th board of directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. CNY 95,000,000 will be included in the capital surplus and the registered capital is increased from CNY 110,000,000 to CNY 115,000,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.36 CNY | -1.45% | +1.49% | -32.42% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.42% | 2.04B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 100 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd